A set of changes to TikTok’s law enforcement policy make it easier for the company to share users’ personal information with government and “regulatory authorities.” TikTok did not respond to repeated ...
SEC foes match up when the No. 17 Tennessee Volunteers (5-2) and the Kentucky Wildcats (2-4) square off on Saturday, October 25, 2025 at Kroger Field. Odds provided by BetMGM. This watch guide was ...
The streaking Indianapolis Colts (6-1) carry a three-game winning streak into a home game against the Tennessee Titans (1-6) on Sunday, October 26, 2025 at Lucas Oil Stadium. Odds provided by BetMGM.
The ABC spoke with Professor Kimberlee Weatherall who is an AI regulation expert from the University of Sydney. She says finding the middle ground between supporting innovation and compensating ...
SEOUL/SHANGHAI, Oct 17 (Reuters) - Micron (MU.O), opens new tab plans to stop supplying server chips to data centres in China after the business failed to recover from a 2023 government ban on its ...
Developers have withdrawn a proposal to rezone more than 600 acres in Jones County, Georgia, after local opposition. The Crooked Creek Technology Park project is led by EagleRock Partners, which is ...
Institutional investors this year planned to put fewer funds into real estate, while the gap between what they actually put into the sector compared to what they planned to, widened. Large investors ...
SINGAPORE: When engaged couple Kevin and Rachel visited a local wedding fair to pick vendors for their ceremony, they chose a Taiwanese bridal studio because it offered the look they wanted at a ...
Microsoft had a slight beat on overall revenue in the quarter, but a miss in cloud was the big disappointment, causing its stock to fall in after-hours trading. Overall, its revenue was $69.6 billion, ...
Internet services company VeriSign reported an over 7 per cent rise in third-quarter revenue on Thursday, driven by steady demand for domain registrations as businesses build their online presence.
Exelixis Inc. (NASDAQ:EXEL) stock is trading lower on Monday after the company shared detailed results from the STELLAR-303 Phase 3 trial. In June, the company said the study met one of its dual ...